Comparing treatments for reducing dark circles caused by rhinitis
Official title: Camillian Saint Mary's Hospital Luodong
Run by Camillians Saint Mary's Hospital Luodong · NCT05348148 · Data updated 2026-11-12
This study is testing different treatments for people with rhinitis to see which one best helps reduce dark circles under the eyes caused by nasal congestion.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 65 Years |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Camillians Saint Mary's Hospital Luodong Academic / other |
| Locations | 1 site (Luodong, Yilan) |
| Status | Recruiting |
| Started | June 16, 2020 |
| Main results expected | March 31, 2032 |
| Study ends | March 31, 2032 |
| Registry record updated | April 27, 2022 |
| Trial ID | NCT05348148 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 6 to 65 with a clinical diagnosis of moderate to severe allergic or non-allergic rhinitis.
✕Probably not a fit
Patients with chronic rhinosinusitis, recent facial trauma, malignancies, or those currently pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of various treatments for allergic and non-allergic rhinitis in reducing the appearance of shiners, which are dark circles under the eyes caused by nasal congestion. Participants aged 6 to 65 will be randomly assigned to receive different treatment combinations, including oral antihistamines and intranasal corticosteroids. The primary goal is to determine which treatment most effectively alleviates shiners, while secondary outcomes will assess the overall impact on rhinitis symptoms. The study employs a randomized controlled design to ensure reliable results.
Why it matters
Potential benefit: If successful, this study could provide effective treatment options for patients suffering from rhinitis and associated shiners, improving their quality of life.
How similar studies have gone: While there have been studies on rhinitis treatments, this specific focus on shiners is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of moderate to severe rhinitis, either allergic rhinitis or non-allergic rhinitis. Exclusion Criteria: * Chronic rhinosinusitis * Trauma to the forehead or nose * Face surgery * Malignancy * Pregnancy * Respiratory tract infections within a week before beginning the study * Usage of medications for rhinitis within a week before beginning the study
Where it's running
-
Camillian Saint Mary's Hospital Luodong
Luodong, Yilan, Taiwan Recruiting
Study contacts
- Principal investigator: Cheng-Tsung Yang — Camillian Saint Mary's Hospital Luodong
- Study coordinator: Cheng-Tsung Yang
- Email: jjbulebeer@gmail.com
- Phone: 886+926436056
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mannan-Conjugated Allergoids for House Dust M mite Allergy
A new treatment named EP-088_MM09 is being tested to see if it can reduce nasal and eye allergy symptoms (and possibly asthma) in people aged 12 to 65 who are allergic to house dust mites, compared with a placebo.
-
Mannan-conjugated Allergoids for House Dust Mite Allergy
A new treatment called EP-088_MM09 is being tested to see if it can reduce allergy symptoms in people with house dust mite–related nasal allergy, with or without mild asthma.
-
Dog-allergy immunotherapy with Alutard SQ Dog in Swedish practice
This study tests whether Alutard SQ Dog immunotherapy helps adults with moderate-to-severe dog allergy when used in real-world Swedish care.
-
PL-14 Allergy Blocker vs saline spray for seasonal nasal allergies
This study tests whether PL-14 Allergy Blocker, a drug-free nasal gel, reduces nasal allergy symptoms in adults with seasonal allergic rhinitis compared with saline spray.
-
Helping decide between nasal surgery options for chronic hypertrophic rhinitis
A randomized trial will see if a printed patient decision aid helps adults with chronic hypertrophic rhinitis choose between surgical options more confidently and with less regret.
-
Digital app to improve adherence to aeroallergen immunotherapy
This project will test whether a smartphone app can help people with allergic rhinitis keep taking their prescribed aeroallergen immunotherapy for the full treatment course.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.